Overdoses Are Soaring, but Medications Can Reduce Death by 50 Percent. So Why Aren’t We Using Them? | Salon
September 12, 2023. Elizabeth Hlavinka reports on the post-X-waiver landscape of buprenorphine prescribing in the United States.
Sumner County Sheriff Calls for Naloxone in High Schools | WKRN
January 16, 2023. Adam Mintzer covers a Middle Tennessee sheriff’s push to get naloxone in schools.
Top Government Researcher Calls for Easier Access to Drug That Treats Opioid Use Disorder: ‘No Reason Why Not’ | CBS News
November 17, 2022. One day after NIDA director Nora Volkow praised the benefits of expanding methadone access, CBS News editor Kerry Breen provides an overview of the less-than-ideal state of medication-assisted treatment in America.
An Open User’s Journey to Reform Drug Policy in Tennessee | The Opioid Matrix Podcast
October 2022. Co-hosts Jen Lynch and Michael Brown, former DEA agent, discuss the landscape of harm reduction in Tennessee — explained from the perspective of someone who uses drugs.
What It’s Like to Seek Medication-Assisted Treatment for Opioid Use: ‘I Broke Down Crying’ | Today
September 2, 2022. Kerry Breen details the many difficulties, barriers, and inconveniences associated with medication-assisted treatment for opioid use disorder.
Drug Users Are Nostalgic for ‘Old-School Heroin’ as Fentanyl Takes Over | VICE
November 3, 2021. Vice senior editor Manisha Krishnan uses personal testimony from Daniel Patrick Garrett, Tennessee Harm Reduction’s founding director, about the ever-growing trend of fentanyl and fentanyl analogues replacing heroin in North American illicit opioid markets.
State Sticking to Its Approach on Opioid Epidemic | The Daily Memphian
May 2, 2021. Featured in a Daily Memphian article, authored by Ian Round, about the Volunteer State’s response to the opioid epidemic. The Tennessee District Attorneys General Conference also published the article as part of their “Fentanyl: The Deadliest High” campaign.
Fit for Recovery | The Weakley County Press
March 23, 2021. Briefly covered a recovery group for a Lifeline Peer Project Regional Coordinator.
When My Suboxone Doctor Quit on Me, It Left a Frightening Void | Filter
February 2, 2021. Philly-based freelance journalist Brandon Dorfman covers the problems faced by medication-assisted treatment enrollees.
Shining a Light on Rural Tennessee | The Social Exchange Podcast
May 15, 2020. Host Zach Rhoads discusses all things harm reduction in rural Tennessee with guest Daniel Patrick Garrett, founding director of Tennessee Harm Reduction.
Lessons in Taking Things One Day at a Time, from People in Recovery | Slate
April 2, 2020. Harm reduction community favorite Zachary Siegel discusses COVID’s then-newfound impact on people in recovery.
Abstracts & Presentations
The Sad State of High-Dose Naloxone: Part II | The Southern Harm Reduction Conference of 2023
September 22, 2023. An extenuation of our presentation at the previous year’s SHRC, I present our findings from “High-Dose Naloxone Formulations Are Not as Essential as We Thought” (link below).
West Tennessee SSP Panel | Supporting Drug User Health; Mentoring the Next Generation — Southern Style
March 21, 2023. At an event put on by Meharry Medical College, presenters from most of West Tennessee’s syringe exchanges — A Betor Way, PEAS, Tennessee Harm Reduction, and WeCareTN — discuss challenges, best practices, and opportunities.
The Sad State of High-Dose Naloxone | The Southern Harm Reduction Conference of 2022
August 27, 2022. Marking Tennessee Harm Reduction’s first presentation at a harm reduction conference, “The Sad State of High-Dose Naloxone” covers the many problems with high-dose naloxone products such as NARCAN® and Kloxxado®. Prerecorded version only.
Publications
High-Dose Naloxone Formulations Are Not as Essential as We Thought
August 14, 2023. As Tennessee Harm Reduction’s first academic publication, this literature review dissects the current body of research on high-dose naloxone formulations (HDNF). We found no evidence that HDNF are necessary for the vast majority of opioid overdose reversals, including cases involving fentanyl.